Merck KGaA has swooped in and bought US-based Sigma-Aldrich in a deal worth $17 billion (€13.1 billion). The acquisition will …
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics

